|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets: | |||
| Current assets | |||
| Prepaid expenses | |||
| Cash | |||
| Prepaid expense | |||
| Prepaid insurance – short-term | |||
| Total Current Assets | |||
| Deferred offering costs | |||
| Prepaid insurance – long-term | |||
| Cash and marketable securities held in Trust Account | |||
| TOTAL ASSETS | |||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | |||
| Liabilities | |||
| Current liabilities | |||
| Accrued expenses | |||
| Accrued offering costs | |||
| Promissory note – related party | |||
| Total Current Liabilities | |||
| Deferred legal fee | |||
| Advisory fee payable - non-current | |||
| Deferred underwriting fee payable | |||
| Total Liabilities | |||
| Class A ordinary shares subject to possible redemption, 28,750,000 shares at a redemption value of $10.13 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders’ Deficit | |||
| Ordinary shares, value | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| Total Liabilities and Shareholders’ Deficit |
Loading...
